Author: Ming Zhong; Aijun Sun; Ting Xiao; Ge Yao; Ling Sang; Xia Zheng; Jinyan Zhang; Xuejuan Jin; Lei Xu; Wenlong Yang; Peng Wang; Kai Hu; Dingyu Zhang; Junbo Ge
Title: A Randomized, Single-blind, Group sequential, Active-controlled Study to evaluate the clinical efficacy and safety of a-Lipoic acid for critically ill patients with coronavirus disease 2019(COVID-19) Document date: 2020_4_21
ID: mvsnybbo_11
Snippet: Patients in the treatment group were treated with ALA (1200 mg/d, intravenous infusion) once daily plus for 7 days on top of standard medical care. Patients in the control group were treated with equal volume saline infusion on top of standard medical care for 7 days. ALA is discontinued when the treatment plan is completed or the patient meets the halfway withdrawal criteria. Withdrawal criteria: (1) The subject himself requested to withdraw fro.....
Document: Patients in the treatment group were treated with ALA (1200 mg/d, intravenous infusion) once daily plus for 7 days on top of standard medical care. Patients in the control group were treated with equal volume saline infusion on top of standard medical care for 7 days. ALA is discontinued when the treatment plan is completed or the patient meets the halfway withdrawal criteria. Withdrawal criteria: (1) The subject himself requested to withdraw from the trial; (2) An intolerable adverse event or an adverse event that the investigator believes must be withdrawn from the study; (3) Those who cannot be treated according to the protocol, have poor compliance, or the physician believes that they should withdraw from the trial.
Search related documents:
Co phrase search for related documents- adverse event and control group patient: 1
- adverse event and intravenous infusion: 1, 2, 3
- adverse event and medical care: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21
- adverse event and poor compliance: 1, 2
- adverse event and standard medical care: 1
- adverse event and study withdraw: 1
- control group and equal volume: 1, 2, 3, 4, 5
- control group and equal volume saline: 1, 2, 3
- control group and intravenous infusion: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19
- control group and medical care: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- control group and poor compliance: 1, 2, 3, 4, 5, 6, 7
- control group and standard medical care: 1, 2, 3, 4, 5, 6, 7, 8, 9
- control group and study withdraw: 1
- control group patient and intravenous infusion: 1
- control group patient and medical care: 1, 2
- equal volume and intravenous infusion: 1, 2
- equal volume and medical care: 1
- equal volume saline and intravenous infusion: 1
- equal volume saline infusion and intravenous infusion: 1
Co phrase search for related documents, hyperlinks ordered by date